Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 140,022 | 135,023 | 120,129 | 123,467 | 120,368 |
| Cost of Goods | 66,182 | 63,855 | 61,619 | 60,111 | 64,542 |
| Gross Profit | 73,840 | 71,168 | 58,510 | 63,356 | 55,826 |
| Operating Expenses | 40,589 | 34,191 | 35,901 | 38,644 | 34,754 |
| Operating Income | 33,433 | 37,832 | 23,228 | 24,823 | 21,614 |
| Interest Expense | 398 | 528 | 566 | 397 | 355 |
| Other Income | -251 | 3,899 | -229 | -1,529 | 7,071 |
| Pre-tax Income | 32,784 | 41,203 | 22,433 | 22,897 | 28,330 |
| Income Tax | 6,752 | 7,290 | 6,559 | 5,551 | 4,077 |
| Net Income Continuous | 26,032 | 33,913 | 15,874 | 17,346 | 24,253 |
| Net Income | $26,032 | $33,913 | $15,874 | $17,346 | $24,253 |
| EPS Basic Total Ops | 0.54 | 0.71 | 0.32 | 0.35 | 0.50 |
| EPS Basic Continuous Ops | 0.54 | 0.70 | 0.32 | 0.36 | 0.50 |
| EPS Diluted Total Ops | 0.50 | 0.64 | 0.30 | 0.33 | 0.47 |
| EPS Diluted Continuous Ops | 0.50 | 0.65 | 0.30 | 0.33 | 0.47 |
| EPS Diluted Before Non-Recurring Items | 0.52 | 0.67 | 0.32 | N/A | N/A |
| EBITDA(a) | $39,985 | $44,286 | $29,902 | $30,963 | $27,581 |